| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $34.3B | $36.8B | $35.5B | $33.5B | $27.8B | $6.4B | $5.0B | $4.5B |
| Cost of Revenue | $26.1B | $27.3B | $26.1B | $23.0B | $19.9B | $15.4B | $13.7B | $12.4B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.7B | $3.6B | $3.2B | $2.9B | $2.6B | $2.0B | $1.8B | $1.7B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $3.6B | $4.8B | $4.7B | $5.9B | $4.2B | $0.8B | $0.5B | $0.5B |
| EPS (Basic) | $11.62 | $14.44 | $13.93 | $16.65 | $11.56 | $2.28 | $1.37 | $1.24 |
| EPS (Diluted) | $11.57 | $14.34 | $13.82 | $16.51 | $11.41 | $2.24 | $1.35 | $1.22 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $35.5B | $36.1B | $32.6B | $30.4B | $24.0B | $18.9B | $15.6B | $14.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $3.0B | $4.5B | $3.9B | $2.5B | $3.2B | $3.0B | $1.5B | $1.5B |
| Total Liabilities | $10.7B | $10.3B | $9.4B | $10.6B | $8.8B | $6.8B | $5.3B | $5.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $24.2B | $25.3B | $22.7B | $19.4B | $14.9B | $11.8B | $10.0B | $9.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.4B | $2.2B | $4.3B | $0.6B | $0.5B | $1.4B | $0.9B | $0.5B |
| Investing Cash Flow | $-0.2B | $-0.2B | $-0.3B | $-0.4B | $-0.3B | $-0.2B | $-0.4B | $0.0B |
| Capital Expenditures | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-4.8B | $-1.4B | $-2.7B | $-0.8B | $-0.1B | $0.3B | $-0.5B | $-0.1B |